RA
AEON.WS

Ramius Advisors’s AEON Biopharma Inc AEON.WS Stock Holding History

Ramius Advisors’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-65,792
Closed -$3K – 117
2022
Q4 		$3K Sell
65,792
-30,000
-31% -$1.21K ﹤0.01% 100
2022
Q3 		$6K Hold
95,792
– – ﹤0.01% 162
2022
Q2 		$14K Buy
+95,792
New +$20.1K 0.01% 150
2022
Q1 		– Sell
-68,879
Closed -$35K – 136
2021
Q4 		$35K Buy
68,879
+56,479
+455% +$31.2K 0.01% 305
2021
Q3 		$7K Buy
+12,400
New +$9.08K ﹤0.01% 226

Other funds holding AEON.WS

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
AC
Athos Capital Hong Kong $324M AUM 16.62% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Ramius Advisors's AEON.WS Position: Q1 2023 in Review

Ramius Advisors sold out of AEON Biopharma Inc (AEON.WS) in Q1 2023, closing a stake of 65,792 shares — an estimated $3K sold.

Ramius Advisors first reported a position in AEON.WS in Q3 2021 and held it in 5 quarters. The position peaked at $35K in Q4 2021. 49 funds tracked by Wall St. Rank hold AEON.WS as of Q1 2023.

  • Ramius Advisors reported no remaining AEON Biopharma Inc position as of Q1 2023 after selling out during the quarter.
  • Ramius Advisors sold 65,792 AEON Biopharma Inc shares in Q1 2023, an estimated $3K.
  • Ramius Advisors first reported a position in AEON Biopharma Inc in Q3 2021 and held it in 5 quarters.
  • Ramius Advisors's AEON Biopharma Inc position peaked at $35K in Q4 2021.
  • 49 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q1 2023.

Based on Ramius Advisors's 13F filing for Q1 2023, filed 11 May 2023.